In conclusion, we demonstrated the correlation of p63 expression and better survival outcomes in patients with high-risk DLBCL, ABC-DLBCL with WT-TP53, and biology associated with p63 expression supporting p63's tumor suppressor role in DLBCL. The gene discussed is TP63; the disease is diffuse large B-cell lymphoma.